RecruitingPhase 3NCT03769766

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance


Sponsor

University of Texas Southwestern Medical Center

Enrollment

291 participants

Start Date

Mar 11, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.


Eligibility

Sex: MALEMin Age: 40 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether taking curcumin (a natural compound found in turmeric) can slow the growth of low-risk prostate cancer in men who are being closely monitored rather than immediately treated — a strategy called "active surveillance." **You may be eligible if...** - You are between 40 and 89 years old - You have low-risk, localized prostate cancer confirmed by biopsy (at least 8 cores taken) - Your biopsy may have been done within the last 12 months - No more than 4 separate areas of your prostate show cancer **You may NOT be eligible if...** - You have intermediate- or high-risk prostate cancer - You have already received treatment for prostate cancer (surgery, radiation, or hormone therapy) - You have certain health conditions that prevent you from taking curcumin supplements safely - You have allergies to curcumin or turmeric products Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCurcumin

Take medication one 500 mg pill of BCM-95 taken twice daily

DRUGPlacebo

Take medication one 500mg pill twice daily


Locations(1)

UT Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03769766


Related Trials